Ayurcann Holdings Corp.

AYURF · OTC
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income-$1,104-$2,601-$520-$119
Dep. & Amort.$165$243$222$271
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$0$0$0
Change in WC-$148$2,299$683$455
Other Non-Cash$321$650-$52$15
Operating Cash Flow-$1,066$805$332$622
Investing Activities
PP&E Inv.-$8-$6-$2-$42
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow-$8-$6-$2-$42
Financing Activities
Debt Repay.-$5-$51-$379$34
Stock Issued$0$0$0$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$44$132-$204-$174
Financing Cash Flow-$49$81-$583-$141
Forex Effect-$37$53$0$0
Net Chg. in Cash-$859$718-$253$439
Supplemental Information
Beg. Cash$1,642$924$1,333$894
End Cash$783$1,642$1,080$1,333
Free Cash Flow-$1,077$796$330$579